MedTrace Logo

Feasibility Study of Dragonfly System for Severe Tricuspid Regurgitation

NCT04921605 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-03-29

No results posted yet for this study

Summary

The study is designed to assess the feasibility of the DragonFly transcatheter mitral valve clamping system for the treatment of symptomatic severe tricuspid regurgitation.

Conditions

  • Tricuspid Regurgitation

Interventions

DEVICE

DragonFly transcatheter mitral valve clamping system

To conduct edge-to-edge repair with Dragonfly System under the guidance of transesophageal echocardiography.

Sponsors & Collaborators

  • Hangzhou Valgen Medtech Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Jianan Wang, MD, PH.D · Second Affiliated Hospital, School of Medicine, Zhejiang University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2022-09-15
Completion
2023-06-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04921605 on ClinicalTrials.gov